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upon sodium dodecyl sulphate challenge was reversed by 
the application of  T. arjuna bark extract.  T. arjuna bark extract 
decreased TEWL, improved skin moisturization, reduced 
scaliness and led to significantly improved skin elasticity. 
Also, increases in blood microflow and skin sebum content 
as well as improved skin thickness/echogenicity were noted 
on postmenopausal skin, resulting in visible reduction of 
sagging skin on the jowls as demonstrated by digital pho-
tography.  Conclusion:  T. arjuna bark extract appears as an 
innovative active ingredient that exerts versatile antiaging 
properties in vitro and in vivo.  © 2013 S. Karger AG, Basel 
 Introduction 
 Skin aging represents a highly complex but not yet ful-
ly understood progressive, multifaceted process  [1] . It is 
currently thought that a variety of different factors con-
tribute to the global expression of skin aging. Similar to 
the entire organism, the skin is subject to an unprevent-
able intrinsic aging process. Cellular aging and shorten-
ing of telomeres, mutations of mitochondrial DNA, oxi-
dative stress, genetic mutations and decrease of several 
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 Abstract 
 Background: Pentacyclic triterpenoids improve epidermal 
barrier function and induce collagen production. Here, their 
effects on cutaneous aging by means of objective instru-
mental measurements were elucidated.  Methods: Reconsti-
tuted human epidermis, cultivated keratinocytes and fibro-
blasts were incubated with  Terminalia arjuna triterpenes 
( T. arjuna bark extract), and mRNA and protein expression of 
various genes was determined using microarray analysis, 
qRT-PCR and ELISA techniques. Clinical efficacy of  T. arjuna 
bark extract versus vehicle control cream was elucidated in 
30 patients and transepidermal water loss (TEWL), skin hy-
dration and elasticity were measured. Another 30 female pa-
tients in their postmenopausal phase were treated with a 
similar regime, and skin sebum content, cutaneous blood 
microcirculation and skin density/echogenicity were as-
sessed.  Results: Incubation with  T. arjuna triterpenes in-
creased FGF-2, TSP-1, TGF-β and CTGF expression, and VEGF 
secretion in vitro. Elevated lactate dehydrogenase release 
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hormone levels are currently thought to contribute to in-
trinsic aging  [2] . In particular, oestrogens affect several 
skin functions and the oestrogen deprivation that accom-
panies menopause contributes to, and exacerbates, the 
deleterious effects of age on the skin  [3] . In addition, skin 
aging is also significantly influenced by exogenous factors 
 [1] such as chronic UV light exposure  [4] . The formation 
of reactive oxygen species and the induction of matrix 
metalloproteinases (MMPs) reflect the central aspects of 
both intrinsic and extrinsic cutaneous aging  [1] . Despite 
some morphological and pathophysiological differences 
underlying the various types of skin aging, all of them 
share some common characteristics such as dermal atro-
phy, loss of collagen density, reduction in dermal cell 
populations and decreased microvasculature  [5] . Other 
commonly experienced physiological changes observed 
during cutaneous aging include impairment of barrier 
function, xerosis, loss of elasticity and slower turnover of 
epidermal cells  [6] . 
 Also, a progressive reduction in water-binding capac-
ity and changes in cutaneous permeability for chemical 
substances has been observed  [7] . However, proper sus-
tenance of the skin is very important, since it represents 
the largest organ of the human body and needs to fulfil 
multiple metabolic tasks. 
 The first evidence of clinical signs associated with skin 
aging is often found in the periorbital area and includes 
wrinkles, eyelid bags, circles around the eye, or a ‘tired’ 
look  [8] . Anti-aging and moisturizing products claim to 
counteract the visible signs of aging, mainly by stimulat-
ing dermal processes and assisting the skin to maintain 
an appropriate level of humidity. However, only a few 
cosmetic preparations are available which have proven 
efficient based on objective quantitative methods. 
 Triterpenoids constitute the major components of 
many traditional medicinal plants  [9] . They represent a 
large family of complex structures synthesized in plants 
via cyclisation of squalene and have been used in tradi-
tional Asian medicine for centuries  [9] . They are well 
known for their anti-inflammatory, immunomodulatory, 
hepatoprotectory, analgetic and antitumour effects  [9–
11] . In addition, pentacyclic triterpenoids have been de-
scribed in the literature for their various beneficial effects 
on skin, including improvement of epidermal barrier 
function, promotion of keratinocyte differentiation and 
induction of collagen production  [12–14] , and thus have 
potential in targeting typical features of cutaneous aging.
 In this study, we aimed to elucidate the effects of a cos-
metic cream containing predominantly triterpenoids as 
the active principle, which were obtained by extraction 
from the bark of the arjun tree. Skin absorption proper-
ties were determined and several in vivo and in vitro pa-
rameters commonly utilized to describe cutaneous aging 
were assessed by means of objective instrumental mea-
surements. 
 Materials and Methods  
 The active ingredients in  Terminalia arjuna bark extract are 
pentacyclic triterpenes which were obtained by extraction from 
the bark of the arjun tree. Briefly,  T. arjuna bark is cleaned, cut and 
pulverized. The resulting coarse powder is extracted at elevated 
temperature with organic solvent. The extract is filtered and con-
centrated under vacuum to a paste. The product is purified by 2 
additional extractions and a filtration step before it is crystallized 
to yield a fine powder. Dissolving about 8% of the powder in pen-
tylene glycol yields a standardized extract consisting of approxi-
mately 90% triterpenoids of which 60–65% are arjunolic acid and 
25–30% are asiatic acid. The biologically active form of  T. arjuna 
triterpenes ( T. arjuna bark extract) has some obstacles when it 
comes to processing in cosmetic formulations at physiologically 
relevant concentrations.  T. arjuna bark extract is neither soluble 
in water nor in most cosmetic oils. It can only be formulated at low 
concentrations in a high amount of a very hot and polar oil phase 
or as a solution in ethanol or pentanediol. Due to these formula-
tion restrictions, TEGO ® Arjuna S was developed. TEGO ® Arjuna 
S is a standardized solution of  T. arjuna bark extract in 1,2-pen-
tanediol with a minimum of 7% triterpenoids. 
 In vitro Culturing of Reconstituted Human Epidermis Models 
 Reconstituted human epidermis was purchased from SkinEth-
ic (Nice, France) and incubated for 24 h in standard maintenance 
medium at 37   °   C and 5% CO 2 as previously described  [15] before 
starting the experiments. 
 In order to evaluate the general biological effects of  T. arjuna 
bark extract, the reconstituted human epidermis was topically 
treated with a thin liquid (O/W) formulation containing 0.5%  T. 
arjuna bark extract for 12 or 24 h, respectively. Reconstituted hu-
man epidermis treated with an O/W formulation without active 
ingredient served as control. Subsequently, tissues were harvested 
and lysed and the total RNA was isolated. 
 For assessment of gene expression, total RNA was extracted 
after incubation as described elsewhere  [7] . DNA chip technique 
was used to evaluate the effect of  T. arjuna bark extract on the ge-
netic level of human skin models. In brief, RNA samples were tran-
scribed into cDNA serving as a template for the in vitro genera-
tion of fluorescently labelled RNA. Affymetrix HGU133 plus 2.0 
GeneChips (Affymetrix Inc., Santa Clara, Calif., USA) were used 
to characterize genome-wide expression using 2 μg of total RNA 
pooled from three reconstituted human epidermis skin models. 
Gene chip assays and initial analysis were carried out as previous-
ly described  [16] . After screening, TaqMan analysis of specific 
transcripts for vascular endothelial growth factor (VEGF), fibro-
blast growth factor receptor 2 (FGFR2) and thrombospondin-1 
(TSP-1) was performed with predesigned and optimized Assays-
on-Demand (Applied Biosystems). Relative quantification was 
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 Gene and Protein Analysis on Human Epidermal 
Keratinocytes 
 Primary normal human epidermal keratinocytes cultivated un-
der non-differentiating conditions were treated with 5 and 10 ppm 
 T. arjuna bark extract, 10 ppm  Centella asiatica triterpenes or 10 
ppm soy isoflavones for 6 or 24 h, respectively; 1,2-pentanediol 
(0.05%) was used as vehicle control. Samples were harvested and 
snap frozen until RNA isolation was performed. The cell culture 
supernatant was stored at –20    °    C for further protein analysis.
Gene expression of VEGF, fibroblast growth factor (FGF-2), TSP-1, 
transforming growth factor β (TGF-β), connective tissue growth 
factor (CTGF) and glycerin aldehyde phosphate dehydrogenase 
(GAPDH) were determined using qRT-PCR as described before 
 [7] . The following gene-specific primers were used. VEGF: forward 
5 ′ -CT A CCTCCACCATGCCAAGT-3 ′ and reverse 5 ′ -GCGAGT C-
T GT G T TTTTGCAG-3 ′ ; FGF-2: forward 5 ′ -GGAGAAGAGCGA-
CC C T C AC-3 ′ and reverse 5 ′ -AGCCAGGTAACGGTTAGCAC-
3 ′ ; TSP-1: forward 5 ′ -GCCTGATGACAAGTTCCAAGA-3 ′ and re-
verse 5 ′ -CT TTGCGATGCGGAGTCT-3 ′ ; TGF-β: forward 5 ′ -
GCCCTGGA CACCAACTATTGCT-3 ′ and reverse 5 ′ -AGG C T -
C CA AA TG TA GG GGCAGG-3 ′ , and CTGF: forward 5 ′ -TGC C -
C GG GA AA TG C TGCGAG-3 ′ and reverse 5 ′ -TGCACAGGCG-
GCTCTGCTTC-3 ′ . GAPDH served as a reference gene with the 
following primer pair: forward 5 ′ -ACCACAGTCCATGCCAT-
CAC-3 ′ and reverse 5 ′ -TCCACCACCCTGTTGCTGTA-3 ′ .
 Production of VEGF protein was analysed in the cell culture 
supernatant using common ELISA techniques (Invitrogen Corpo-
ration, Camarillo, Calif., USA) according to the manufacturer’s 
instructions.
 Overall Gene Expression Analysis (GeneChips) on Human 
Dermal Fibroblasts 
 Cultured primary human dermal fibroblasts were cultivated 
with 5 and 10 ppm  T. arjuna bark extract, 10 ppm  C. asiatica tri-
terpenes, 10 ppm soy isoflavones or 10 ng/ml TGF-β (positive con-
trol) for 6 h; 1,2-pentanediol (0.05%) was used as vehicle control. 
Samples were harvested and snap frozen until RNA isolation was 
performed. DNA chip technique was used to evaluate global effects 
of  T. arjuna bark extract on gene expression in human dermal fi-
broblasts.
 Cellular Protection against External Stress 
 To elucidate the potential protecting effect of  T. arjuna bark 
extract against external stress, reconstituted human epidermal 
skin models (SkinEthic) were topically treated with 0.5%  T. arjuna 
bark extract solubilized in an appropriate vehicle (propylene gly-
col) for 24 h. Application of propylene glycol served as vehicle 
control. Afterwards, skin models were challenged for 40 min with 
0.25% sodium dodecyl sulphate (SDS, solution in phosphate-buff-
ered saline, PBS, pH 7.4) to create cell damage and tissue irritation. 
Subsequently, the treatment with the test solutions (vehicle vs.  T. 
arjuna bark extract) for 24 h was repeated. Cell culture superna-
tants were collected 48 h after the second application for analysis 
of lactate dehydrogenase (LDH) release as cell damage marker. 
Additionally, 52 h after SDS treatment cell viability was deter-
mined by XXT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide) photometric assay (Cell Prolifera-
tion Kit II, Roche Applied Science).
 Penetration Properties of T. arjuna Bark Extract in an ex vivo 
Pig Skin Model 
 The penetration properties of  T. arjuna bark extract were de-
termined in the context of a cosmetic emulsion. On the one hand, 
the extract was added to the oil phase of the formulation, while, on 
the other hand, a presolution of  T. arjuna bark extract in 1,2-pen-
tanediol (TEGO ® Arjuna S) was added to the emulsion at the end 
of the production process. The formulations were analysed with 
respect to skin penetration and formulation stability. 
 The study is based on the OECD guideline (OECD Guideline 
for the Testing of Chemicals, Skin Absorption: in vitro Method, 
TG 428, adopted 13 April 2004). Application conditions were cho-
sen to mimic reality as closely as possible. The integrity of the por-
cine skin was examined with caffeine. 
 Porcine skin was used to determine the cutaneous absorption 
of the test substance applied in formulation. For the oil phase of 
the emulsion PPG-3 myristyl ether (TEGOSOFT ® APM) was used 
as relatively polar oil, caprylic/capric triglyceride (TEGOSOFT ® 
CT) was used as a representative of a medium polar oil and min-
eral oil was used as a non-polar emollient.
 A skin layer of a defined thickness (about 1,000 μm) containing 
the stratum corneum, epidermis and part of the dermis was pre-
pared with a dermatome. Punched circular pieces of porcine skin 
were placed in suitable diffusion chambers (Franz diffusion cells) 
for the testing. Approximately 20 mg/cm 2 of the test formulations 
were applied on the porcine skin and the dermis side of the porcine 
skin disc was in contact with receptor fluid during the experiment. 
The diffusion cells were placed in a climate chamber at defined 
conditions (32  °  C, 50% relative humidity) for 24 h reflecting in-use 
conditions. After 24 h, the residual test formulation was collected 
from the skin surface with a cotton swab, and the skin was cut into 
small pieces for extraction. Finally, the amount of active ingredient 
from the cotton swab, the skin extraction and the receptor fluid 
were determined analytically.
 Improvement of Skin Moisturization and Elasticity in vivo  
 In order to investigate the effects of T. arjuna bark extract on 
skin moisturization and elasticity 30 panellists (mixed panel) were 
recruited. The study was conducted in wintertime. A total of 15 
volunteers received an O/W formulation containing 0.25%  T. ar-
juna bark extract, while the other 15 panellists received the for-
mulation without active ingredient (vehicle). Each panellist ap-
plied the test formulation twice daily for 8 weeks on the inner 
forearm. Prior to application and after 4 weeks of treatment
transepidermal water loss (TEWL) and skin hydration were mea-
sured with a Tewameter TM 300 and a Corneometer CM 825, 
respectively (Courage + Khazaka, Cologne, Germany), as previ-
ously described  [7] .
 In addition, skin scaliness was determined using the Visioscan 
VC 98 (Courage + Khazaka) prior to application of the formula-
tion and 4 weeks after usage  [7] .
 The effect of  T. arjuna bark extract on skin elasticity was 
determined after 8 weeks by measuring R1 and R5 using a Cu-
tometer MPA 580 (Courage + Khazaka)  [7] . R1 represents the 
ability of the skin to return to its original state (R1 = Uf – Ua) 
 [18] . R5 is considered the net elasticity of the skin without the 
viscous deformation. Elastic recovery is represented by the ratio 
of the immediate retraction to immediate distension (R5 = Ur/
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 All measurements were carried out under standardized condi-
tions in a climate room at 22  °  C and 50–52% relative humidity. The 
panellists were resting under these climate conditions for a mini-
mum of 15 min before determination of skin parameters.
 Reducing Symptoms of Postmenopausal Skin in vivo 
 In order to evaluate the effect of  T. arjuna bark extract on char-
acteristic symptoms of postmenopausal skin, including reduced 
sebum production, microcirculation and skin thickness, 40 Cau-
casian women (aged 50–70 years) in their postmenopausal period 
were included in a subsequent in vivo study. Exclusion criteria 
were any kind of skin disease and recent usage of anti-wrinkle 
treatments. The volunteers were instructed to avoid any addition-
al facial creams and to circumvent exposure to UV light during the 
study period.
 Each volunteer received two formulations, which were applied 
twice daily on either side of the face.  T. arjuna  bark extract was 
tested at a concentration of 0.2%. The formulation was prepared by 
adding a solution of  T. arjuna bark extract in 1,2-pentanediol to the 
emulsion after the homogenization step below 40   °   C. The tested 
concentration equals 2.5% TEGO ® Arjuna S. Soy isoflavones were 
tested as market benchmark for mature skin care. A formulation 
without active ingredient was used as a negative control. 
 At baseline and after 4, 8, and 12 weeks of application, skin se-
bum content was measured using a Sebumeter SM 810 (Courage 
+ Khazaka), according to the manufacturer’s instructions. Cutane-
ous blood microcirculation was determined using a Flowmeter 
Periflux PF4001 (Perimed, Stockholm, Sweden) which is based on 
the laser Doppler method. With this technique the total local mi-
crocirculatory blood perfusion including the perfusion in capillar-
ies (nutritive flow), arterioles, venules and shunting vessels can be 
determined. A beam of laser light emitted by a fibre-optic probe is 
partially reflected and partially absorbed by the examined tissue. 
Light hitting moving blood cells undergoes a change in wavelength 
(Doppler shift), while light hitting static objects is unchanged. The 
perfusion is expressed in perfusion units which are arbitrary units 
determined by the Doppler device.
 Skin density/echogenicity was assessed with an ultrasound 
scanner, Dermascan C ® (Cortex Technology, Hadsund, Den-
mark) in B-scan mode and expressed in percent. Digital images 
were taken for clinical evaluation after receiving written consent 
from the patient.
 Statistical Analysis 
 Results are presented as mean ± SEM (in vitro n = 3 per group 
at each time point, unless otherwise stated). The data were ana-
lysed using Student’s t test, and differences were considered sig-
nificant at a p value of <0.05, unless otherwise stated.
 Results 
 Treatment with T. arjuna Bark Extract Leads to 
Altered Gene Expression in Cutaneous Cells in vitro 
 Microarray analysis of reconstituted human epidermis 
treated with  T. arjuna bark extract revealed a significant 
gene regulatory activity of this compound. A total of 42 
genes were at least 2-fold up- or downregulated after 12 
or 48 h (data not shown). For selected candidates, the re-
sults of the microarray analysis were verified by qRT-PCR 
using the TaqMan method ( fig. 1 ).
 Treatment of human reconstituted epidermis with  T. 
arjuna bark extract resulted in approximately a 10-fold 
increase of TSP-1 gene expression after 48 h of applica-
tion compared to vehicle ( fig. 1 a). Also, a 3-fold increase 
in VEGF and a 30-fold increase in FGFR2 gene expres-
sion after 12 h of application were noted when compared 







Vehicle 0.5% T. arjuna 
bark extract
Vehicle 0.5% T. arjuna 
bark extract


































 Fig. 1. TSP-1 ( a ), VEGF ( b ) and FGFR2 ( c ) gene expression in human reconstituted epidermis models after treat-
ment with  T. arjuna bark extract at different time points measured by qRT-PCR. The results are calculated rela-
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 Treatment of human epidermal keratinocytes with 10 
ppm of  T. arjuna bark extract significantly increased TSP-
1 and VEGF gene expression compared to vehicle after 6 h 
of application ( fig. 2 a, b). While incubation with  C. asiati-
ca  triterpenes also led to significant increases in VEGF ex-
pression, administration of soy isoflavones did not signifi-
cantly alter expression of this gene. Significant increases in 
FGF-2, CTGF and TGF-β expression could be detected af-
ter 24 h of incubation with 5 and 10 ppm of  T. arjuna bark 
extract. Also, treatment with  C. asiatica triterpenes was as-
sociated with significant increases in FGF-2 and CTGF at 
24 h after administration. Incubation with soy isoflavones 
led to significant upregulation of FGF-2 and TGF-β and 
significant decrease in TSP-1 expression ( fig. 2 a, c–e). 
 Treatment of human epidermal keratinocytes with 5 
ppm of  T. arjuna bark extract further resulted in signifi-
cant VEGF protein production compared to vehicle. Even 
though 10 ppm of  T. arjuna bark extract also increased 
VEGF levels, this increase was not statistically significant 
( fig. 3 a).
 Microarray analysis of human dermal fibroblasts 
treated with different concentrations of  T. arjuna bark 
extract revealed a dose-dependent, more than 2-fold 
downregulation of IL-8 and MMP-1 gene expression 
compared to vehicle control ( table 1 ). Both reference sub-
stances,  C. asiatica triterpenes and soy isoflavones, also 
reduced the gene expression of these markers 3- to 6-fold. 
The positive control TGF-β showed a 3-fold reduction in 



































T. arjuna bark extract (5 ppm)
T. arjuna bark extract (10 ppm)
C. asiatica triterpenes (10 ppm)












































 Fig. 2. TSP-1 ( a ), VEGF ( b ), FGF-2 ( c ), CTGF ( d ), TGF-β ( e ) gene expression in human epidermal keratinocytes 
after treatment with test substances at different time points measured by qRT-PCR. The results are calculated 
relative to vehicle and normalized to GAPDH gene expression.  * p < 0.05,  * * p < 0.01,  * * * p < 0.001 vs. vehicle. 
Table 1.  Excerpt of genes regulated in human dermal fibroblasts 





T. arjuna bark extract, 5 ppm –1.73 –2.30
T. arjuna bark extract, 10 ppm –2.20 –2.73
C. asiatica triterpenes, 10 ppm –2.82 –3.37
Soy isoflavones, 10 ppm –3.04 –6.04
TGF-β, 10 ng/ml –3.05 –3.54
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 T. arjuna Bark Extract Protects Epidermal Cells 
against External Stress 
 SDS challenge of reconstituted human epidermal skin 
resulted in a significantly increased LDH release after
48 h, indicating membrane defects of the cells. Applica-
tion of  T. arjuna bark extract prior to SDS challenge 
markedly reduced LDH release by 78% ( fig. 4 a). Also, in-
cubation with SDS significantly reduced cell viability by 
approximately 66%, which was strongly diminished by  T. 
arjuna bark extract pretreatment ( fig. 4 b).
 Penetration Properties and Bioavailability of 
T. arjuna Bark Extract  
 Penetration of  T. arjuna bark extract was very high 
(approx. 50%) when the oil phase of the emulsion was 
based on a polar emollient like PPG-3 myristyl ether. The 
good bioavailability could be improved up to about 70% 
when  T. arjuna bark extract was added to the formulation 
as a solution in 1,2-pentanediol (TEGO ® Arjuna S). For-
mulating  T. arjuna bark extract in the oil phase of an 
emulsion with a medium polar emollient (caprylic/capric 
triglyceride) led to a bioavailability of approximately 
12%. However, when TEGO ® Arjuna S (solution of  T. 
arjuna bark extract in 1,2-pentanediol) was used instead,
an almost 4-fold increased penetration was achieved. 
Similar results were obtained when the relatively non-po-
lar mineral oil was employed in the emulsion. The bio-
availability of  T. arjuna bark extract was raised from ap-
proximately 14% to more than 25% when using the novel 
product form of TEGO ® Arjuna S in this formulation 
( fig. 5 a).
 In addition, the formulation properties of  T. arjuna 
bark extract can be drastically improved by employing the 
product as a solution in 1,2-pentanediol (TEGO ® Arjuna 
S).  Figure 5 shows microscopic pictures of an O/W emul-
sion where the pure  T. arjuna bark extract was dissolved 
in the hot oil phase of the emulsion ( fig. 5 b) in compari-
son to adding TEGO ® Arjuna S to the emulsion at the end 
of the production process ( fig. 5 c). It can easily be seen 
that the use of  T. arjuna bark extract without 1,2 pentane-
diol in the oil phase led to formation of crystals in the 
finished formulation. By contrast, no crystallization was 
observed when TEGO ® Arjuna S was employed.
 Administration of T. arjuna Bark Extract Improves 
Skin Moisturization and Elasticity in vivo 
 In vivo data revealed that administration of  T. arjuna 
 bark extract for 4 weeks led to a marked decrease in TEWL 
by approximately 46% compared to vehicle ( fig. 6 a). Also, 
daily treatment with  T. arjuna bark extract for 4 weeks 
Vehicle
T. arjuna bark extract (5 ppm)
T. arjuna bark extract (10 ppm)
C. asiatica triterpenes (10 ppm)




































































 Fig. 3. Relative VEGF release in cell culture supernatant 24 h after 
application of test substances.  * p < 0.05 vs. vehicle. 
 Fig. 4. LDH release and cell viability after SDS challenge.  a LDH 
release 48 h after application of test substances.  b Cell viability 
(XTT assay) 52 h after application of test substances. Student’s t 
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PPG-3 myristyl ether Caprylic/capric triglycerides Mineral oil
b c
 Fig. 5. (a) Penetration profile of  T. arjuna 
bark extract in comparison to TEGO ® Ar-
juna S. Shown are microscopic images of 
formulations prepared by (b) disolving 
pure T. Arjuna bark extracts or (c) the solu-
tion in pentanediol (TEGO ® Arjuna S) out 
of a formulation with different oil phases. 
Skin penetration is calculated as percent 
bioavailability in porcine skin. 
d e
Vehicle 0.25% T. arjuna
bark extract









































































 Fig. 6. TEWL ( a ), skin moisturization ( b ) 
and skin scaliness ( c ) after 4 weeks of ap-
plication of  T. arjuna bark extract. Stu-
dent’s t test:  +++ p < 0.001,  ++ p < 0.01 vs. 
start,  + p < 0,05, (+) p < 0.1 vs. start,  * p < 
0.05, ( * ) p < 0.1 vs. vehicle (n = 30). Exem-
plary image of the inner forearm of a vol-
unteer taken by Visioscan before applica-
tion ( d ) and 4 weeks after application ( e ) of 





















   
   
   
   
   
   
   
   
   
   
   













































































0.2% T. arjuna bark extract
Soy isoflavones 
Vehicle
0.25% T. arjuna bark extract
Soy isoflavones 
Vehicle
0.2% T. arjuna bark extract
Soy isoflavones 
Vehicle






















































































































 Fig. 7. Skin elasticity after 8 weeks of appli-
cation of  T. arjuna bark extract.  a Elasticity 
parameter R1.  b Elasticity parameter R5. 
Student’s t test:  + p < 0.05 vs. start (n = 30). 
 Fig. 8. Amount of sebum on the skin ( a ), skin blood microflow ( b ), 
skin density/echogenicity ( c ) and decrease of sagging skin ( d ) rela-
tive to the beginning after 4, 8, and 12 weeks of application of  T. 
arjuna bark extract. PU = Perfusion units. Student’s t test:  +++ p < 
0.001,  ++ p < 0.01,  + p < 0.05, ( + ) p < 0.1 vs. start;  * * p < 0.01, ( * ) p < 
0.1 vs. vehicle (n = 30). Digital images of a representative volunteer 
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was associated with a significant 4-fold increase in corne-
ometer units compared to vehicle, indicating improved 
skin moisturization ( fig. 6 b). Scaliness was reduced by ad-
ministration of both vehicle and 0.25%  T. arjuna  bark 
extract. However, the latter led to more pronounced re-
duction, which was also visualized by digital images 
( fig. 6 c–e). 
 Daily application of 0.25%  T. arjuna bark extract for
8 weeks was also associated with significantly improved 
skin elasticity as indicated by a significant reduction of R1 
and a significant increase of R5 ( fig. 7 a, b). 
 Administration of T. arjuna Bark Extract Reduces 
Symptoms of Postmenopausal Skin in vivo 
 In the subsequent in vivo target study including exclu-
sively postmenopausal women, administration of  T. ar-
juna bark extract for a period of 8 and 12 weeks increased 
facial skin sebum content by 24 and 61%, respectively, 
compared to baseline ( fig. 8 a). Although application of 
soy isoflavones also evoked an enhanced sebum content, 
this increase was not statistically significant compared to 
vehicle. Similar results were obtained with respect to skin 
blood microcirculation: while daily application of  T. ar-
juna bark extract led to a significantly increased blood 
microflow, administration of soy isoflavones did not 
show significant alterations of blood microcirculation 
compared to vehicle ( fig. 8 b). In vivo data also demon-
strated significantly improved skin thickness/echogenici-
ty after 12 weeks of application of  T. arjuna bark extract. 
However, similar results were obtained with soy isofla-
vones ( fig.  8 c). Visual and tactile clinical evaluation of 
skin sagging by a dermatologist confirmed the results of 
the objective measurements and revealed a significant re-
duction of skin sagging after 4, 8 and 12 weeks of daily 
application of  T. arjuna bark extract. Neither the admin-
istration of soy isoflavones nor vehicle could significantly 
alter skin sagging ( fig. 8 d). The visible reduction of sag-
ging skin on the jowls by  T. arjuna bark extract was also 
demonstrated using digital photography ( fig. 8 e, f).
 Discussion 
 Based on the various known beneficial effects of pen-
tacyclic triterpenoids on the skin  [12–14] , we aimed to 
determine their effects on cutaneous aging using various 
objective in vitro and in vivo measurements. 
 Cutaneous aging may be considered as the accumula-
tion of different deleterious changes in cells and tissues 
 [1] and occurs in all individuals at a variable rate that is 
influenced by genetic, environmental and hormonal fac-
tors and may thus be divided into two basic processes: 
intrinsic aging, also referred to as chronological aging, 
and extrinsic aging. Extrinsic aging primarily arises from 
chronic UV light exposure, while, for example, hormonal 
changes during perimenopausal years clearly contribute 
to intrinsic aging  [20] . Nevertheless, both types of cutane-
ous aging share several molecular similarities including 
formation of reactive oxygen species and the induction of 
MMPs  [1] . Reactive oxygen species may induce expres-
sion of MMP-1, -3 and -9 via activation of c-Jun and ac-
tivator protein-1 and reduce the expression of procolla-
gen-1  [21] . Indeed, increased levels of partially degraded 
collagen have been found in intrinsically aged and photo-
aged skin. UV radiation also activates nuclear factor kap-
pa B that stimulates the transcription of proinflammatory 
cytokine genes such as IL-1b, TNF-a, IL-6 and IL-8  [22] . 
 Importantly, treatment with  T. arjuna bark extract led 
to altered gene expression in cutaneous cells in vitro. Spe-
cifically, incubation of human dermal fibroblasts with  T. 
arjuna bark extract resulted in a dose-dependent, more 
than 2-fold downregulation of MMP-1 and IL-8 gene
expression, indicating inhibitory effects on MMP-1 and 
proinflammatory cytokine activities. Also, treatment of 
human epidermal keratinocytes with  T. arjuna bark ex-
tract resulted in significant increases in VEGF, TSP-1, 
FGF-2, CTGF and TGF-β mRNA expression as well as 
enhanced VEGF protein production. Notably, changes
in mRNA expression were more pronounced upon  T.
arjuna bark extract incubation compared to incubation 
with  C. asiatica triterpenes or soy isoflavones. Similar in-
creases in TSP-1, VEGF and FGFR2 gene expression were 
noted after treatment of reconstituted human epidermis 
with  T. arjuna bark extract. Thus, alteration of these 
genes may represent some potential mechanisms of ac-
tion of  T. arjuna bark extract in the prevention of cutane-
ous aging, since it was recently demonstrated that reduc-
tion of CTGF and impaired TGF-β ⁄Smad signalling may 
significantly contribute to diminished type-I procollagen 
in intrinsically aged skin  [23] . FGF-2 induces endothelial 
cell proliferation and migration. Moreover, it increases 
the synthesis of matrix macromolecules and hyaluronic 
acid by stimulating the gene expression of hyaluronan 
synthases  [24] . FGF-2 also contributes to the wound-
healing process by stimulating fibroblast proliferation 
and by inhibiting the expression of MMP-1 in keratino-
cytes  [25] . FGF-2 and its receptor FGFR2 may be also re-
lated to enhanced sebaceous gland activity with increased 
sebum production  [26] . Its upregulation in keratinocytes 
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contribute to the increased skin sebum content as ob-
served in our clinical experiments.
 VEGF represents a potent angiogenic factor  [27] and 
its 121-, 165- and 189-amino-acid isoforms are predomi-
nantly found in human keratinocytes  [28] . VEGF pro-
motes endothelial proliferation during formation of new 
blood vessels. Physiologically, VEGF is expressed at rela-
tively low levels in adult skin. Insufficient oxygen supply 
in the skin induces upregulation of VEGF gene expres-
sion by epidermal keratinocytes and dermal fibroblasts. 
Postmenopausal and photoaged skin have been reported 
to display an age-dependent reduction of cutaneous mi-
crovasculature, which may explain several of the physi-
ological alterations that are characteristic of old skin, 
 including pallor, decreased skin temperature, reduced 
cutaneous vascular responsiveness and decreased nutri-
tional supply  [29, 30] . Thus, a moderate induction of 
VEGF favouring a better blood supply – as shown by ad-
ministration of  T. arjuna bark extract in vitro and in vivo 
– may be warranted. 
 TSP-1 is a large multimeric ECM protein and has been 
well characterized as a potent endogenous regulator in 
epithelial tissues, including the skin  [31] . Its epidermal 
overexpression has been recently shown to inhibit dermal 
photodamage, as well as collagen and elastic fibre disor-
ganization, thus potentially preventing the formation of 
skin wrinkles  [32] . 
 As demonstrated in our experiments,  T. arjuna bark 
extract was easily incorporated into cosmetic emulsions 
when applied as a solution in pentanediol (TEGO® Ar-
juna S). An additional benefit of this product form is the 
enhanced bioavailability, which was also increased when 
formulating with more polar emollients  [33] .
 The suggested effects of  T. arjuna bark extract demon-
strated in vitro were then further evaluated in vivo with 
respect to potential antiaging properties using a represen-
tative patient population. Instrumental and clinical eval-
uations of patients included into the clinical study showed 
significant improvements in skin moisturization and 
elasticity as well as a reduction in scaliness with results 
better than those of the vehicle group. Sensitive, aged and 
dry skin is associated with increased TEWL, increased 
penetrability and higher susceptibility to irritants, leading 
to impaired barrier function. In vivo data revealed that 
administration of  T. arjuna bark extract led to a marked 
decrease in TEWL compared to vehicle, indicating recov-
ery of epidermal barrier function.
 We also could demonstrate a strong beneficial effect of 
 T. arjuna bark extract on postmenopausal skin. Admin-
istration of  T. arjuna bark extract significantly increased 
skin sebum content and skin blood microcirculation 
compared to vehicle. Although application of soy iso-
flavones also evoked an enhanced sebum content, this
increase was not statistically significant compared to
vehicle. In vivo data also demonstrated significantly im-
proved skin thickness/echogenicity after 12 weeks of ap-
plication of  T. arjuna bark extract similar to that of pa-
tients receiving soy isoflavones. Moreover, daily 
administration of  T. arjuna  bark extract revealed a sig-
nificant reduction of skin sagging, which was not ob-
served upon administration of soy isoflavones or vehicle. 
 Soy isoflavones are known to have various biological 
effects through oestrogen receptor activity and are often 
used in cosmetic formulation for mature skin  [34, 35] . 
However, they contain estrogenic metabolites and pos-
sess phytohormonal activity, which is often not desired. 
Also, their precise mechanism of action in skin is still un-
known, and their possible side effects have not been well 
investigated  [3] .  T. arjuna bark extract has a comparable 
activity on cutaneous ageing without influencing hor-
mone metabolism, as demonstrated in an oestrogen re-
ceptor-binding study (data not shown). 
 Conclusion 
 T. arjuna bark extract appears as an innovative active 
ingredient that alters various genes in vitro which are in-
volved in cutaneous ageing and has been demonstrated to 
exert various antiaging properties in vivo.
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